Colitis and Crohn Disease: A True/False Test

March 3, 2019

By Ted W. James, MD

Slideshow

True or False: Smoking causes IBD flares; peak IBD onset occurs in 3rd decade; UC affecting the rectum increases risk of colon cancer; plus 3 more.

Recent Videos

Related Content

Guselkumab (Tremfya) Gains FDA Approval for Crohn Disease: Daily Dose / image credit: ©New Africa/AdobeStock

Guselkumab (Tremfya) Gains FDA Approval for Crohn Disease: Daily Dose

Sydney Jennings

Your daily dose of the clinical news you may have missed.

Clostridium difficile: New Guidelines Confront Hypervirulent Strain

Christina M. Surawicz, MD

Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.

Dupilumab Shows Efficacy in Eosinophilic Esophagitis Regardless of Food Elimination Diets

Dupilumab Shows Efficacy in Eosinophilic Esophagitis Regardless of Food Elimination Diets

Sydney Jennings

The impact of food elimination diets on medication previously was unknown, according to new research presented at AAAAI 2025.

Clinical Tips for Using Antibiotics and Corticosteroids in IBD

Clinical Tips for Using Antibiotics and Corticosteroids in IBD

Raymond Cross, MD

January 5th 2013

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

Minimally Invasive Esophageal String Test Used to Monitor Eosinophilic Esophagitis in Children / Image credit: ©Naeblys/AdobeStock

Minimally Invasive Esophageal String Test Used to Monitor Eosinophilic Esophagitis in Children

Sydney Jennings

January 27th 2025

Researchers at Phoenix Children’s Hospital conducted one of the largest real-world clinical evaluations of the esophageal string test in children.

FDA Approves Mirikizumab for Crohn Disease: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Mirikizumab for Crohn Disease: Daily Dose

Sydney Jennings

January 27th 2025

Your daily dose of the clinical news you may have missed.

Related Content

Guselkumab (Tremfya) Gains FDA Approval for Crohn Disease: Daily Dose / image credit: ©New Africa/AdobeStock

Guselkumab (Tremfya) Gains FDA Approval for Crohn Disease: Daily Dose

Sydney Jennings

Your daily dose of the clinical news you may have missed.

Clostridium difficile: New Guidelines Confront Hypervirulent Strain

Christina M. Surawicz, MD

Recurrent C difficile requires pulse vancomycin therapy; fecal microbiota transplant shows promise.

Dupilumab Shows Efficacy in Eosinophilic Esophagitis Regardless of Food Elimination Diets

Dupilumab Shows Efficacy in Eosinophilic Esophagitis Regardless of Food Elimination Diets

Sydney Jennings

The impact of food elimination diets on medication previously was unknown, according to new research presented at AAAAI 2025.

Clinical Tips for Using Antibiotics and Corticosteroids in IBD

Clinical Tips for Using Antibiotics and Corticosteroids in IBD

Raymond Cross, MD

January 5th 2013

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

Minimally Invasive Esophageal String Test Used to Monitor Eosinophilic Esophagitis in Children / Image credit: ©Naeblys/AdobeStock

Minimally Invasive Esophageal String Test Used to Monitor Eosinophilic Esophagitis in Children

Sydney Jennings

January 27th 2025

Researchers at Phoenix Children’s Hospital conducted one of the largest real-world clinical evaluations of the esophageal string test in children.

FDA Approves Mirikizumab for Crohn Disease: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Mirikizumab for Crohn Disease: Daily Dose

Sydney Jennings

January 27th 2025

Your daily dose of the clinical news you may have missed.

Editorial Board

Terms and Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.